UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038407
Receipt number R000043768
Scientific Title Brain health effect test by continuous intake of high cacao chocolate
Date of disclosure of the study information 2019/10/29
Last modified on 2020/10/28 19:06:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Brain health effect test by continuous intake of high cacao chocolate

Acronym

Brain health effect test by cacao chocolate

Scientific Title

Brain health effect test by continuous intake of high cacao chocolate

Scientific Title:Acronym

Brain health effect test by cacao chocolate

Region

Japan


Condition

Condition

Healthy adul

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Allocate 100 healthy adults to two groups, the group that randomly ingests the test food and the group that does not ingest, and compare the brain activity after each test food intake.

Basic objectives2

Others

Basic objectives -Others

brain structure

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Structure MRI

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Every day, 25 g of the chocolate in intervention period

Interventions/Control_2

no chocolate

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

64 years-old >=

Gender

Male and Female

Key inclusion criteria

All subjects voluntarily signed the informed consent after detailed description and understanding of this study

Key exclusion criteria

1) Those who may suffer from allergy by administering cacao, milk or soybean.
2) Those who were included other clinical trials within one month before giving written informed consent, or during this study.
2) Any other reasons unfavorable to participation in this <RI study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yasuharu
Middle name
Last name Koike

Organization

Tokyo Institute of Technology

Division name

IIR

Zip code

226-8503

Address

4259, Nagatsuta-cho midoriku yokohama kanagawa

TEL

045-924-5054

Email

koike@cns.pi.titech.ac.jp


Public contact

Name of contact person

1st name Yasuharu
Middle name
Last name Koike

Organization

Tokyo Institute of Technology

Division name

IIR

Zip code

226-8503

Address

4259, Nagatsuta-cho midoriku yokohama kanagawa

TEL

045-924-5054

Homepage URL


Email

koike@cns.pi.titech.ac.jp


Sponsor or person

Institute

BHQ

Institute

Department

Personal name



Funding Source

Organization

BHQ

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Institute of Technology

Address

2-12-1, Oookayama, Meguro-ku, Tokyo

Tel

03-5734-3808

Email

hitorinri@jim.titech.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

104

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 10 Month 01 Day

Date of IRB

2019 Year 09 Month 24 Day

Anticipated trial start date

2019 Year 10 Month 28 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 10 Month 28 Day

Last modified on

2020 Year 10 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043768


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name